These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28031161)

  • 1. Leucotriene receptor antagonists for asthma can save millions, says NICE.
    Wise J
    BMJ; 2016 Dec; 355():i6835. PubMed ID: 28031161
    [No Abstract]   [Full Text] [Related]  

  • 2. A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).
    Price D; Musgrave S; Wilson E; Sims E; Shepstone L; Blyth A; Murdoch J; Mugford M; Juniper E; Ayres J; Wolfe S; Freeman D; Lipp A; Gilbert R; Harvey I
    Health Technol Assess; 2011 May; 15(21):1-132. PubMed ID: 21554855
    [No Abstract]   [Full Text] [Related]  

  • 3. Budget busters.
    Cresswell J
    Community Nurse; 1999 Oct; 5(9):10. PubMed ID: 10732567
    [No Abstract]   [Full Text] [Related]  

  • 4. Pressure point. When coughing up is essential.
    Cooper C
    Health Serv J; 2000 Nov; 110(5733):suppl 1. PubMed ID: 11138527
    [No Abstract]   [Full Text] [Related]  

  • 5. Asthma medication.
    Rogol PR
    Conn Med; 2008 Aug; 72(7):441. PubMed ID: 18763675
    [No Abstract]   [Full Text] [Related]  

  • 6. Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
    Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):181-9. PubMed ID: 16136769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis.
    Armstrong EP; Malone DC
    Pharmacotherapy; 2002 Sep; 22(9):1117-23. PubMed ID: 12222547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting the gold standard: clinical and economic decision making in asthma management.
    O'Connor RD
    Manag Care; 2003 Jan; 12(1 Suppl):11-7. PubMed ID: 18567330
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of antileukotrienes in the treatment of asthma.
    Barnes NC
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S73-6. PubMed ID: 10673231
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharma focus. Puff adders.
    Chapman S
    Health Serv J; 2003 Nov; 113(5883):suppl 6-7. PubMed ID: 14671867
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukotriene antagonists in asthma.
    Lipworth B; Jackson C
    N Engl J Med; 2011 Jul; 365(3):272-3; author reply 273-4. PubMed ID: 21774722
    [No Abstract]   [Full Text] [Related]  

  • 12. Asthma treatment guidelines meet the real world.
    Dahlén SE; Dahlén B; Drazen JM
    N Engl J Med; 2011 May; 364(18):1769-70. PubMed ID: 21542748
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukotriene receptor antagonists for exacerbations of asthma.
    Welsh E; Chavasse R; Watts K; Cates C
    Paediatr Respir Rev; 2012 Dec; 13(4):226-7. PubMed ID: 23069120
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of leukotriene receptor antagonists (LTRAs) in the management of asthma.
    Haughney J
    Scott Med J; 1999 Apr; 44(2):37-8. PubMed ID: 10370978
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukotriene Receptor Antagonists in the Treatment of Acute Asthma.
    Van Leer P
    Am Fam Physician; 2016 Apr; 93(7):552. PubMed ID: 27035038
    [No Abstract]   [Full Text] [Related]  

  • 16. Montelukast in guidelines and beyond.
    Bousquet J; Demoly P; Humbert M
    Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction to the Global Initiative for Asthma and the new guidelines.
    Partridge MR
    West Indian Med J; 2003 Jan 20-21; 52 Suppl 7():6-9. PubMed ID: 15042755
    [No Abstract]   [Full Text] [Related]  

  • 18. Montelukast: new preparation. No current use in asthma.
    Prescrire Int; 1999 Oct; 8(43):131-4. PubMed ID: 11503835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Diamant Z; Sterk PJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene receptor antagonists as first line or add-on treatment for asthma.
    Ducharme FM
    BMJ; 2011 Sep; 343():d5314. PubMed ID: 21914735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.